MAVERICS Graft System

About Medical 21

Medical 21 is a private, pre-revenue medical device innovator targeting a fundamental limitation in cardiovascular surgery: the need for vessel harvesting in bypass procedures. The company's core technology is the MAVERICS Graft, a biocompatible, nitinol-scaffold-based implant that leverages the body's regenerative pathways to guide the formation of a new, arterial-like blood vessel. By providing an off-the-shelf synthetic graft, Medical 21 seeks to expand patient eligibility, reduce procedure time and complications, and improve outcomes for the millions of patients undergoing CABG surgery worldwide, a field that has seen little innovation for over 60 years.

Therapeutic Areas

Other Coronary Artery Bypass Graft (CABG) Surgery Drugs